The new USDT-settled product tracks Novo Nordisk (NVO), trades 24/7, supports Bybit's futures bots and carries an every-eight-hour funding cycle with a 2% cap.
Bybit has opened trading for the NVOUSDT perpetual contract, a USDT-settled derivatives product tied to Novo Nordisk (NVO), with up to 25x leverage. The contract trades 24/7, has a tick size of 0.01, settles funding fees every eight hours and caps the funding rate at 2%. Bybit said the market is available for manual trading and through its Futures Grid, Futures Martingale and Futures Combo bots. The exchange also said it may adjust launch timing and contract parameters, including leverage, margin rates, order-size limits, funding rate, and mark and index price calculations.